This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
Clinical Epigenetics Open Access 04 November 2015
-
The DAC system and associations with acute leukemias and myelodysplastic syndromes
Investigational New Drugs Open Access 14 December 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 1998; 95: 3003–3007.
Bernhard D, Skvortsov S, Tinhofer I, Hubl H, Greil R, Csordas A et al. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. Cell Death Differ 2001; 8: 1014–1021.
Kawagoe R, Kawagoe H, Sano K . Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways. Leukemia Res 2002; 26: 495–502.
Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP . Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Exp Hematol 2005; 33: 53–61.
Borgmann A, Baldy C, von Stackelberg A, Beyermann B, Fichtner I, Nurnberg P et al. Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol 2000; 17: 635–650.
Fichtner I, Paal K, Borgmann A, Badiali L, Wurm R, Henze G . Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias – correlation to the expression of multidrug resistance proteins. Anticancer Res 2003; 23: 2657–2664.
Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC et al. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res 2001; 7: 962–970.
Coffey DC, Kutko MC, Glick RD, Butler LM, Heller G, Rifkind RA et al. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res 2001; 61: 3591–3594.
Acknowledgements
We gratefully acknowledge S Shalapour for technical help with Western blotting and L Badiali for performing initial flow cytometry assays. This work was supported by a grant of Kind-Philipp-Stiftung für Leukämieforschung e.V. (to LK) and a grant of Deutsche José Carreras Leukämie-Stiftung e.V. (to HGE; DJCLS R 05/18).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Einsiedel, H., Kawan, L., Eckert, C. et al. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia. Leukemia 20, 1435–1436 (2006). https://doi.org/10.1038/sj.leu.2404282
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404282
This article is cited by
-
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
Clinical Epigenetics (2015)
-
Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions
Drugs (2013)
-
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
Leukemia (2012)
-
The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells
Leukemia (2011)
-
Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy
Leukemia (2010)